ArticleFrontiers in oncology2023

The efficacy and safety of epirubicin and cyclophosphamide combined with pyrotinib in neoadjuvant treatment for HER2-positive breast cancer: A real-world study.

Fu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.